Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Adapthealth Corp(AHCO)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AHCO
09/18/2026: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.
AdaptHealth Corp. is a national provider of home medical equipment and services, including sleep therapy, respiratory supplies, and diabetes management. The company has historically grown through an aggressive acquisition strategy, which established a wide geographical reach and a robust recurring revenue base from medical supply replenishments. Its primary opportunity lies in the shift toward home-based care for aging populations, while its main risks include high financial leverage, heavy reliance on government reimbursement rates, and intense competition from larger distributors. The company may appeal to investors looking for exposure to home-care trends, though it is currently not a dividend-paying stock and requires monitoring of its deleveraging progress.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company is transitioning from an aggressive growth phase to a focus on organic growth and profitability. |
| Momentum investor | Weak fit | The stock has experienced significant volatility and is currently not reflecting a strong upward momentum signal. |
| Value investor | Mixed fit | Valuation may appear attractive following pullbacks, but the debt profile requires careful scrutiny. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses capital on debt reduction. |
| Low-risk investor | Weak fit | High leverage and regulatory exposure to CMS reimbursement make this a higher-risk profile. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is susceptible to sector-wide sentiment and changes in healthcare policy. |
| Valuation risk | Medium | Future growth expectations are heavily tied to the company's ability to maintain organic growth rates. |
| Competition risk (National Healthcare Providers) | Medium | The sector faces pricing pressure from large national distributors and potential retail competitors. |
| Business quality | Medium | While the business model is recurring, it is heavily dependent on regulatory reimbursement environments. |
| Dividend income | Low / none | Investors should not expect income generation from this stock. |
| Execution risk | Medium | Successfully managing a large, integrated national network requires consistent operational excellence. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -82.12% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/18/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 768.44M USD | Price to earnings Ratio - | 1Y Target Price 9 |
Price to earnings Ratio - | 1Y Target Price 9 | ||
Volume (30-day avg) 3.2M shares | Beta 1.39 | 52 Weeks Range 5.21 - 13.43 | Updated Date 09/18/2026 |
52 Weeks Range 5.21 - 13.43 | Updated Date 09/18/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.67 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Sleep Therapy | CPAP machines, masks, and recurring replacement supplies. | Revenue comes from both initial device setup and steady, recurring revenue from mask and supply replacements. |
| Respiratory/Diabetes | Oxygen concentrators, CGMs, and insulin pumps. | These products provide long-term recurring revenue as patients require consistent supply replenishment. |
| Geography | United States-based patient care delivery. | The company operates exclusively within the US, making it highly dependent on US healthcare policies and Medicare reimbursement. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 7.78 | Enterprise Value 2.81B | Price to Sales(TTM) 0.23 |
Enterprise Value 2.81B | Price to Sales(TTM) 0.23 | ||
Enterprise Value to Revenue 0.84 | Enterprise Value to EBITDA 9.73 | Shares Outstanding 133.41M | Shares Floating 85.77M |
Shares Outstanding 133.41M | Shares Floating 85.77M | ||
Percent Insiders 8.18 | Percent Institutions 108.49 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Adapthealth Corp
Exchange NASDAQ | Headquarters Conshohocken, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10900 | Website https://adapthealth.com |
Full time employees 10900 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.